EPT Disclosure
20 Décembre 2007 - 4:11PM
UK Regulatory
RNS Number:4208K
UBS AG (EPT)
20 December 2007
FORM 38.5(b)
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS
WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RI STATUS
BUT NOT DEALING IN A CLIENT-SERVING CAPACITY
(Rule 38.5(b) of the Takeover Code)
1. KEY INFORMATION
Name of exempt principal trader UBS AG London Branch
Company dealt in Imperial Chemical Industries Plc
Class of relevant security to which the Ord 100p
dealings being disclosed relate (Note 1)
Date of dealing 19 DECEMBER 2007
2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE
(a) Interests and short positions (following dealing) in the class of
relevant security dealt in (Note 2)
Long Short
Number (%) Number (%)
(1) Relevant securities - 0.00% - 0.00%
(2) Derivatives (other than
options)
(3) Options and agreements to
purchase/sell
Total - 0.00% - 0.00%
(b) Interests and short positions in relevant securities of
the company, other than the class dealt in (Note 2)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than
options)
(3) Options and agreements to
purchase/sell
Total
(c) Rights to subscribe (Note 2)
Class of relevant security: Details
3. DEALINGS (Note 3)
(a) Purchases and sales
Purchase/sale Number of securities Price per unit (Note 4)
SALE 4000 667 pence
SALE 4000 667
SALE 4000 667
SALE 4000 667
SALE 4000 667
SALE 4000 667
SALE 4000 667
SALE 3900 667
SALE 2300 667
PURCHASE 4000 667.5
PURCHASE 4000 667.5
PURCHASE 4000 667.5
PURCHASE 4000 667.5
PURCHASE 4000 667.5
PURCHASE 2300 667.5
PURCHASE 4000 667.5
PURCHASE 4000 667.5
PURCHASE 4000 667.5
TOTAL PURCHASES 34,300
TOTAL SALES 34,200
(B) Derivatives transactions (other than options)
Product name, e.g Long/short (Note 5) Number of securities Price per unit
CFD (Note 6) (Note 4)
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, e.g. Expiry Option
name,e.g. selling, securities price American, date money paid/
call purchasing, to which the European received per
option varying etc option etc. unit (Note
relates 4)
(Note 6)
(ii) Exercising
Product name, e.g. call Number of securities Exercise price per unit
option (Note 4)
(d) Other dealings (including new securities) (Note 3)
Nature of transaction Details Price per unit (if applicable)
(Note 7)
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which any
derivative referred to on this form is referenced. If none, this should be
stated.
..............................................................................
..............................................................................
Is a Supplemental Form 38.5(B) attached? (Note 8) NO
Date of disclosure 20 DECEMBER 2007
Contact name NIMISHA SACHDEV
Telephone number 020 7568 9289
Name of offeree/offeror with which connected Imperial Chemical Industries
Plc
Nature of connection (Note 9) CONNECTED ADVISER
Notes
The Notes on Form 38.5(B) can be viewed on the Takeover Panel's website at
www.thetakeoverpanel.org.uk
This information is provided by RNS
The company news service from the London Stock Exchange
END
EMMBUBDDGBDGGRG
Imperial Chemical Industries (LSE:ICI)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
Imperial Chemical Industries (LSE:ICI)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025
Real-Time news about Imp.Chem. (London Stock Exchange): 0 recent articles
Plus d'articles sur Imp. Chemical Inds.